HealthAxis and COPE Health Solutions Form Strategic Partnership to Enhance Value-Based Care
HealthAxis, a leader in healthcare administration technology, has partnered with COPE Health Solutions (CHS), a specialist in value-based care and population health management. This strategic collaboration aims to provide comprehensive,…
DeepCure to Present In Vivo Data on DC-9476, a Superior BRD4 Inhibitor for Rheumatoid Arthritis
DeepCure, a therapeutics company leveraging AI to discover innovative drugs for inflammation and immune diseases, today announced that it will present data demonstrating that its selective BRD4 (BD2) inhibitor, DC-9476,…
AI Software for Breast Arterial Calcification Scoring Predicts Cardiovascular Outcomes in Women, Study Shows
CureMetrix® has announced a new peer-reviewed study confirming the effectiveness of its investigational AI-enabled software for automated breast arterial calcification (BAC) detection in mammograms. This technology can inform personalized risk…
OS Therapies Completes Last Patient Visit for OST-HER2 Osteosarcoma Phase 2b Trial
OS Therapies (NYSE American: OSTX) announced today that the last patient (Patient #41) enrolled in the AOST-2121 clinical trial (NCT04974008) for OST-HER2 in recurrent, resected osteosarcoma has completed their final…
Charles River Showcases Translational Expertise at Neuroscience 2024
Charles River Laboratories International, Inc. (NYSE: CRL) has announced that its neuroscience drug discovery team will present 18 scientific posters at Neuroscience 2024, the annual meeting of the Society for…
Digbi Health to Unveil Study on Gut Microbiome and GLP-1 Production at 2024 Obesity Society Conference
Digbi Health, a leader in Precision Biology and personalized healthcare, has been invited to present a groundbreaking study at the Obesity Society Conference. The research highlights how the Digbi Health…
Virica Biotech and Ginkgo Bioworks Partner to Boost AAV Gene Therapy Production
Ginkgo Bioworks, Inc. is establishing a premier platform for cell programming and biosecurity, while Virica Biotech Inc. specializes in enhancers for scaling viral vectors and cell and gene therapies. The…
Waud Capital Partners Acquires Science Exchange to Enhance Life Sciences Innovation
Science Exchange, a top provider of SaaS solutions for life sciences procurement and supplier management, has announced its acquisition by Waud Capital Partners, a private equity firm focused on growth…
PHC Showcases LiCellGrow Automated Cell Culture Prototype with In-Line Monitoring at Regenerative Medicine JAPAN 2024
PHC to Showcase LiCellGrow Prototype for Automated Cell Culture at Regenerative Medicine JAPAN 2024 PHC Corporation’s Biomedical Division will present the prototype of “LiCellGrow,” an automated cell culture device designed…
Fresenius Kabi and Formycon Gain FDA Approval for Biosimilar Otulfi™ (ustekinumab-aauz)
Fresenius Kabi, part of Fresenius and specializing in biopharmaceuticals, clinical nutrition, and medical technologies, along with Formycon AG, an independent developer of biosimilars, has announced FDA approval for Otulfi™ (ustekinumab-aauz),…
StemCardia Licenses Heart Regeneration Technologies from UW School of Medicine
StemCardia Inc. has secured a license for a range of intellectual property from CoMotion at the University of Washington (UW) and the UW School of Medicine, focusing on next-generation treatments…
Repare Therapeutics Presents Phase 1 Data on Camonsertib and Radiotherapy at ASTRO Annual Meeting
Repare Therapeutics Inc. (Nasdaq: RPTX), a clinical-stage precision oncology company, today shared data showcasing the clinical benefits of camonsertib, a promising oral small molecule ATR inhibitor, used in combination with…